Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Aster DM Quality Care — Q1 FY27 Earnings Presentation
31 slides from Aster Dm Healthcare's earnings presentation, Aug 5, 2026
Slide 1: Investor Presentation intimation letter to stock exchanges
05 August, 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Inv
Slide 2: Earnings Presentation Q1 FY27
Earnings Presentation Q1 FY27
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Quality Care Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other cond
Slide 4: Merger became effective on July 1, 2026 forming Aster DM Quality Care Limited
Merger became effective on July 1, 2026 forming Aster DM Quality Care Limited Executed on schedule with zero operational friction, establishing the cultural foundation required to unlock long-term financial synergies #GO GREATER On Time Building one culture across the combined organisation Merger Ex
Slide 5: Creating a larger platform to make quality healthcare accessible
Creating a larger platform to make quality healthcare accessible 35% - Metro and Tier 1 10,898 Capacity Beds 65% -Tier 2 & Tier 3 28 9 Cities States International Hospitals: 2, Beds: 620 39 2 321 Labs & PECs3 and Hospitals 2054 Pharmacies Madhya Pradesh Hospitals: 1, Beds: 222 Dhaka Chhattisgarh Ind
Slide 6: Strategic rationale behind the merger
Strategic rationale behind the merger ▪ 1. Scale 4. Diversification Merged entity as one of the top 3 hospital Geographically well diversified chains in India and with strong presence platform with low overlap in cities across South and Central India of presence 2. Enhanced Metrics 5. Growth Potenti
Slide 7: Aster DM Quality Care Proforma Performance Highlights
Aster DM Quality Care Proforma Performance Highlights Revenue from Operations (INR Cr) Operational Beds The Combined Entity1 demonstrates Strong YoY Revenue Growth aided by Steady 2,597 Patient Volume growth 2,156 Q1FY27 : 10,559 Q1FY26 : 10,193 • 20% YoY growth in Revenue, reaching INR 2,597 Cr in
Slide 8: Financial Metrics
Combined Proforma Numbers for Q1FY27 Aster + Quality Care1 = Merged Entity* (Figures for Q1FY27) YoY Growth Revenue (INR Cr) 1,311 1,287 2,597 20% Operating EBITDA2 (INR Cr) 277 299 576 30% Financial Metrics Op EBITDA Margin % 21.1% 23.2% 22.2% 170 bps ROCE 3 (%) 22.6% 23.1% 22.9% 246 bps Net Debt (
Slide 9: Operational Metrics
Combined Proforma Numbers for Q1FY27 Aster + Quality Care1 = Merged Entity* (Figures for Q1FY27) YoY Growth No. of Hospitals (Nos) 201 19 39 City Presence (Nos) 16 14 28 Operational Metrics Operational Beds2 (Nos) 5,385 5,174 10,559 3.6% Occupancy (%) 62% 65% 64% 510 bps Total Patient Volume (Mn) 1.
Slide 10: Aster DM Quality Care Overview
Aster DM Quality Care Overview 99
Slide 11: Hospitals & Clinics Revenue Mix Q1FY27
Hospitals & Clinics Revenue Mix Q1FY27 Payor Revenue Mix Specialty-wise Revenue Mix MVT1 4% [3%] Q1FY27 [Q1FY26] Government Health Schemes Cardiac Sciences, 9% [8%] 15% [16%] Others, 38% [38%] Oncology, 10% [10%] Walk-in 53% [56%] Neuro Sciences, 11% [11%] Corporate & Insurance 34% [33%] Nephrology,
Slide 12: Aster DM Quality Care: Q1FY27 Clinical Highlights
Aster DM Quality Care: Q1FY27 Clinical Highlights Our Clinical Excellence • Kerala’s 1st transcatheter Fontan procedure performed at Aster Medcity, Kochi Accreditations • Karnataka’s 1st robotic-assisted revision knee replacement using CORI system at Aster RV, Bengaluru • Highest number of Lymph Ven
Slide 13: Maturity Wise Hospital Performance: Q1FY27
Maturity Wise Hospital Performance: Q1FY27 Key Performance indicators Maturity Operational Beds5 Revenue6 Operating EBITDA6 Operating (INR in Cr) (INR Cr) EBITDA %6 Mature1 65% 73% 86% 29.7% 19% 29% Focus2 14% 15% 10% 16.8% 16% 20% Emerging3 10% 6% 3% 12.4% 63% 240% Hospitals Under4 11% 5% 1% 3.6% 2
Slide 14: Board of Directors
Board of Directors Varun Khanna Alisha Moopen Ayshwarya Vikram Managing Director and Executive Director Non-Executive Director Group CEO Ganesh Mani James Mathew Kewal Handa Non-Executive Director Independent Director Independent Director Sunil Theckath Neeraj Jain P H Vijaya Deepti Vasudevan Indepe
Slide 15: Leadership Team
Leadership Team Sunil Kumar M R Hemish Purushottam Ramesh Kumar Group Company Secretary and Chief Executive Officer Chief Financial Officer Compliance Officer (India I) Dr. Ratnadeep Dr. Pawan Kumar Vishal Maheshwari Chaskar Chief Executive Officer Chief Executive Officer Chief Executive Officer (In
Slide 16: Awards, Rankings & Ratings
Awards, Rankings Ratings Awards, Rankings & Ratings • Lifetime Achievement Award by • ASSOCHAM Awards 2026 – • Lifetime Achievement Award by Financial Express Women Leader in Business Financial Express • ET Entrepreneur Awards - Global • Ranked 4th among Top Women • Legend in the Healthcare Entrepre
Slide 17: Multiple avenues of synergies poised to accelerate growth and profitability
Multiple avenues of synergies poised to accelerate growth and profitability Academics, Nursing Business KPI & & Talent Sharing Reporting Standardization 10 11 Renewable Energy 9 Material Cost Optimization 2 Savings (Pharmacy, Consumables etc.) Indirect Cost Optimisation GROUP International (AMC / CM
Slide 18: Planned Expansion across Aster DM Quality Care
Planned Expansion across Aster DM Quality Care Addition of 4,179 beds, bringing the total bed capacity to 15,077 beds 800 15,077 1,555 1,190 634 10,898 180 454 430 760 1,360 195 250 550 FY30 and beyond: FY27: 634 beds FY28: 1,190 beds FY29: 1,555 beds 800 beds Current Projected 53% Beds in Existing
Slide 19: Aster DM - Performance Highlights Q1FY27
Aster DM - Performance Highlights Q1FY27 18 18
Slide 20: Aster: Key Highlights for Q1FY27
Aster: Key Highlights for Q1FY27 Strong 22% YoY growth in Revenue led by robust performance across Core Hospital & Clinics • Driven by higher patient volumes, stronger specialty and payor mix, clinician additions and the ramp-up of Kasargod • Mature units (~77% of revenue) saw a revenue growth of 19
Slide 21: Aster: Performance Highlights for Q1FY27
Aster: Performance Highlights for Q1FY27 Revenue1 Operating EBITDA1,2 Op EBITDA Margin1,2 RoCE3 Financial Q1FY27 : INR 1,311 Cr Q1FY27 : INR 277 Cr Q1FY27 : 21.1% Q1FY27 : 22.6% 22% 29% 117 bps 190 bps Q1FY26 : INR 1,078 Cr Q1FY26 : INR 215 Cr Q1FY26 : 20.0% Q1FY26 : 20.7% Q1 FY27 (ex-new unit4) > U
Slide 22: Aster: Revenue Mix Q1FY27
Aster: Revenue Mix Q1FY27 Q1FY27 [Q1FY26] Segmental Revenue Mix Specialty-wise Revenue Mix 1 Pharmacy Child & Adolescent Health, 5% [5%] Labs Women's Health, 2% [3%] Cardiac Sciences, 3% [3%] 6% [6%] 13% [13%] Nephrology & Urology, 7% [7%] Oncology, 11% [11%] OP Pharmacy, Anaestheolgy & Hospitals &
Slide 23: Aster: Profitability Statement
Aster : Profitability Statement Particulars Q1FY27 Q1FY26 YoY % Revenue Revenue from Operations 1,311 1,078 22% • Grew by 22% YoY in Q1FY27 driven by higher patient volumes, improved realizations, a stronger specialty and payor mix, doctor Gross Profit 1,019 831 23% additions and the ramp-up of Kasa
Slide 24: Geography wise Business: Snapshot for Q1FY27
Geography wise Business: Snapshot for Q1FY27 Kerala1,2 Karnataka & Maharashtra1 Andhra & Telangana1 INR 687 cr INR 432 cr INR 157 cr Revenue 54% Revenue 34% Revenue 12% ▲ 25% YoY ▲16% YoY ▲33% YoY Capacity Beds 2,988 Capacity Beds 1,579 Capacity Beds 1,157 Operational Beds 2,912 Operational Beds 1,4
Slide 25: 'Women & Children' Facility - Aster Whitefield, Bengaluru
‘Women & Children’ Facility - Aster Whitefield, Bengaluru Expansion aligned with rising demand for high-quality maternal & pediatric care Key Highlights Commissioning In Presence of Investment & Scale Comprehensive Care Offering • Level 3 NICU • Aesthetic & Cosmetic Center Inaugurated in the presenc
Slide 26: Quality Care Performance Highlights
Quality Care Performance Highlights 25 25
Slide 27: Quality Care: Key Highlights for Q1FY27
Quality Care: Key Highlights for Q1FY27 Strong 19% YoY revenue growth for the business driven by robust performance across clusters • Growth driven by higher IP Volumes, favorable shift in payor mix toward cash and insurance and increased share of complex procedures associated with strong clinical h
Slide 28: Quality Care: Performance Highlights for Q1FY27
Quality Care : Performance Highlights for Q1FY27 Revenue Operating EBITDA 1 Op. EBITDA Margin1 RoCE2 Revenue Financial Q1FY27 : INR 1,287 Cr Q1FY27 : INR 299 Cr Q1FY27 : 23.2% Q1FY27 : 23.1% 19% 32% 216 bps 293 bps Q1FY26 : INR 1,079 Cr Q1FY26 : INR 227 Cr Q1FY26 : 21.1% Q1FY26 : 20.2% Operational B
Slide 29: Annexure
Annexure 2 + ##@ =. Aster DM Quality Care Limited 28
Slide 30: Merged entity with robust revenue growth and strong margin profile
Merged entity with robust revenue growth and strong margin profile Aster Quality Care1,2,3 Aster DM Quality Care* 4,643 4,630 9,273 4,138 8,105 3,967 3,699 3,615 7,314 Revenue (INR Cr) FY24 FY25 FY26 FY24 FY25 FY26 FY24 FY25 FY26 Margin Margin Margin 16.8% 19.5% 20.4% 21.5% 21.7% 23.0% 19.1% 20.5% 2
Slide 31: Thank You
THANK YOU
Aster DM Quality Care — Q1 FY27 Earnings Presentation on 6ix